Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, P.R. China.
Center for Gut Microbiome Research, Med-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China.
ACS Nano. 2024 Oct 1;18(39):26807-26827. doi: 10.1021/acsnano.4c07658. Epub 2024 Sep 20.
To realize effective and long-term synergistic therapy of ulcerative colitis (UC) with probiotics, we developed gastrointestinal self-adaptive and nutrient self-sufficient (AKK)-gelatin porous microgels (AKK@GPMGs). In AKK@GPMGs, AKK was covered with sequential layers of proanthocyanidins (PAs), mucin (MUC), and phosphatidylcholine (PC) to obtain AKK@PAs-MUC-PC (AKK@PMP), and then encapsulated within the methacrylate-modified gelatin porous microgels. AKK@GPMGs provide sufficient mucus as a nutrition source for AKK and boost resistance to stomach acid by 30.49-fold, and colonization in the intestines is enhanced by 83.46 times. The microgels can be dissociated by matrix metalloproteinase at the inflammatory sites of the intestine, and release AKK@PMP, which acts as "band-aid" that adheres to the inflamed colon for a long time and offers improved synergistic therapy for UC. Compared to uncoated AKK, AKK@GPMGs increase reactive oxygen species scavenging capacity by 26.47 times, improve the intestinal mucus layer thickness by 5.63 times, increase the goblet cells abundance by 3.93 times, reduce intestinal permeability by 5.60 times and significantly enhance beneficial gut microbiota while repressing harmful microbiota. These results indicate that AKK@GPMGs can restore mucus layer and tight junction integrity, reduce inflammation and oxidative stress, and regulate gut microbiota homeostasis to effectively treat intestinal inflammation.
为了实现溃疡性结肠炎(UC)的益生菌协同治疗的有效性和长期性,我们开发了胃肠道自适性和营养自足的(AKK)-明胶多孔微球(AKK@GPMGs)。在 AKK@GPMGs 中,AKK 被原花青素(PAs)、黏蛋白(MUC)和磷脂酰胆碱(PC)的顺序层覆盖,以获得 AKK@PAs-MUC-PC(AKK@PMP),然后封装在甲基丙烯酰化改性明胶多孔微球内。AKK@GPMGs 提供了足够的黏液作为 AKK 的营养来源,并将耐胃酸能力提高了 30.49 倍,在肠道中的定植能力提高了 83.46 倍。微球可以在肠道的炎症部位被基质金属蛋白酶分解,并释放出 AKK@PMP,它作为“创可贴”长时间附着在发炎的结肠上,为 UC 提供了改进的协同治疗。与未涂层的 AKK 相比,AKK@GPMGs 提高了 26.47 倍的活性氧清除能力,提高了 5.63 倍的肠道黏液层厚度,增加了 3.93 倍的杯状细胞丰度,降低了 5.60 倍的肠道通透性,并显著增强了有益的肠道微生物群,同时抑制了有害的微生物群。这些结果表明,AKK@GPMGs 可以恢复黏液层和紧密连接的完整性,减轻炎症和氧化应激,调节肠道微生物群的平衡,从而有效治疗肠道炎症。